Physician profile
John W Barnes
NPI 1316017262
$4,139.20
in general payments reported to CMS, 2019-2025
15 companies · $749 in 2025
The $749 reported for 2025 was more than what 86% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $502 · 2020: $201 · 2021: $486 · 2022: $767 · 2023: $703 · 2024: $730 · 2025: $749.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,182.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,182.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $772.42 | 2019-2025 | Clariti Contact Lens, Myday Contact Lens |
| Alcon Vision LLC | $725.39 | 2019-2025 | Precision 1, Dailies Total1, Total30 |
| Johnson & Johnson Vision Care, INC. | $721.58 | 2019-2025 | Acuvue |
| Bausch & Lomb Americas INC. | $617.91 | 2022-2025 | Infuse, Miebo, Xiidra |
| Novartis Pharmaceuticals Corporation | $265.84 | 2019-2023 | |
| Oyster Point Pharma, INC. | $253.50 | 2022-2024 | Tyrvaya |
| Topcon Healthcare, INC. | $181.90 | 2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $127.27 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $125.44 | 2020-2024 | |
| Shire North American Group INC | $113.58 | 2019 | |
| Lkc Technologies, INC. | $104.73 | 2024 | |
| Kala Pharmaceuticals, INC. | $55.89 | 2021-2022 | |
| Biotissue Holdings INC. | $33.69 | 2019-2021 | |
| Dompe US, INC. | $26.52 | 2024 | Oxervate |
| Allergan, INC. | $13.54 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Barnes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.